Your browser doesn't support javascript.
loading
European Medicines Agency review of ixazomib (Ninlaro) for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
Tzogani, Kyriaki; Florez, Beatriz; Markey, Greg; Caleno, Mariapaola; Olimpieri, Odoardo Maria; Melchiorri, Daniela; Hovgaard, Doris Johanna; Sarac, Sinan Bardakci; Penttilä, Karri; Lapveteläinen, Tuomo; Salmonson, Tomas; Bergh, Jonas; Gisselbrecht, Christian; Pignatti, Francesco.
Afiliación
  • Tzogani K; European Medicines Agency, Amsterdam, The Netherlands.
  • Florez B; MHRA, London, UK.
  • Markey G; MHRA, London, UK.
  • Caleno M; AIFA, Roma, Italy.
  • Olimpieri OM; AIFA, Roma, Italy.
  • Melchiorri D; Dip. Physiology and Pharmacology, V. Erspamer, University of Rome La Sapienza, Roma, Italy.
  • Hovgaard DJ; Laegemiddelstyrelsen, Kobenhavn, Denmark.
  • Sarac SB; Laegemiddelstyrelsen, Kobenhavn, Denmark.
  • Penttilä K; Finnish Medicines Agency Fimea, Helsinki, Finland.
  • Lapveteläinen T; Finnish Medicines Agency Fimea, Helsinki, Finland.
  • Salmonson T; Lakemedelsverket, Uppsala, Sweden.
  • Bergh J; Radiumhemmet Microbiology and Tumorbiology Center, Karolinska University Hospital, Stockholm, Sweden.
  • Gisselbrecht C; Institut d'Hématologie, Hôpital Saint Louis Paris Diderot Université, Hospital Saint-Louis, Paris, France.
  • Pignatti F; European Medicines Agency, Amsterdam, The Netherlands.
ESMO Open ; 4(5): e000570, 2019.
Article en En | MEDLINE | ID: mdl-31555488

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: ESMO Open Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: ESMO Open Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos